ENZALUTAMIDE and ASTHENIA

Overview

ASTHENIA is the #5 most commonly reported adverse reaction for ENZALUTAMIDE, manufactured by Astellas Pharma US, Inc.. There are 4,120 FDA adverse event reports linking ENZALUTAMIDE to ASTHENIA. This represents approximately 3.5% of all 117,902 adverse event reports for this drug.

Patients taking ENZALUTAMIDE who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ASTHENIA is moderately reported among ENZALUTAMIDE users, representing a notable but not dominant share of adverse events.

Other Side Effects of ENZALUTAMIDE

In addition to asthenia, the following adverse reactions have been reported for ENZALUTAMIDE:

• FATIGUE — 10,159 reports
• DEATH — 7,667 reports
• MALIGNANT NEOPLASM PROGRESSION — 5,409 reports
• PROSTATIC SPECIFIC ANTIGEN INCREASED — 4,295 reports
• DRUG INEFFECTIVE — 4,028 reports
• HOT FLUSH — 3,819 reports
• DECREASED APPETITE — 3,379 reports
• NAUSEA — 3,240 reports
• DIZZINESS — 3,107 reports
• DIARRHOEA — 2,783 reports

Other Drugs Associated with ASTHENIA

The following drugs have also been linked to asthenia in FDA adverse event reports:

Does ENZALUTAMIDE cause ASTHENIA?

ASTHENIA has been reported as an adverse event in 4,120 FDA reports for ENZALUTAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ASTHENIA with ENZALUTAMIDE?

ASTHENIA accounts for approximately 3.5% of all adverse event reports for ENZALUTAMIDE, making it a notable side effect.

What should I do if I experience ASTHENIA while taking ENZALUTAMIDE?

If you experience asthenia while taking ENZALUTAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages